Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

March 1988

Volume 522 Calcium Antagonists: Pharmacology and Clinical Research

Pages 1–798

  1. Part I. Physiology

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Historical Overview : The Calcium Channel of the Heart (pages 1–15)

      ALBRECHT FLECKENSTEIN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33337.x

    2. Calcium Channels in the Heart : Properties and Modulation by Dihydropyridine Enantiomers (pages 16–24)

      H. REUTER, H. PORZIG, S. KOKUBUN and B. PROD'HOM

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33338.x

    3. Calcium Channel Modulation by Dihydropyridines in Vascular Smooth Muscle (pages 25–31)

      KENT HERMSMEYER, MICHAEL STUREK and NANCY J. RUSCH

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33339.x

    4. Voltage-Dependent Calcium Channel in Intestinal and Vascular Smooth Muscle Cells (pages 32–42)

      T. B. BOLTON, P. I. AARONSON and I. MacKENZIE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33340.x

  2. Poster Papers

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Monoclonal Antibody Characterization of the 1,4-Dihydropyridine Receptor of Rabbit Skeletal Muscle (pages 43–46)

      ALBERT T. LEUNG, TOSHIAKI IMAGAWA and KEVIN P. CAMPBELL

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33341.x

  3. Part II. Biochemistry

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Historical Overview : Calcium Ion and Contractile Proteins (pages 51–59)

      SETSURO EBASHI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33343.x

    2. Vascular Smooth Muscle Sarcoplasmic Reticulum : Function and Mechanisms of Ca2+ Release (pages 60–73)

      C. van BREEMEN, K. SAIDA, H. YAMAMOTO, K. HWANG and C. TWORT

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33344.x

    3. Calmodulin and Its Activation by Cadmium Ion (pages 74–87)

      WAI YIU CHEUNG

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33345.x

    4. Interaction of Calcium with Receptor-Stimulated Phosphoinositide Hydrolysis in Brain and Liver (pages 88–95)

      F. T. CREWS, R. A. GONZALES, R. RAULLI, R. McELHANEY, N. PONTZER and M. RAIZADA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33346.x

    5. Cyclic Nucleotides and Calcium Regulation in Heart and Smooth Muscle Cells (pages 106–115)

      JEAN-CLAUDE STOCLET, CHANTAL BOULANGER-SAUNIER, BERNARD LASSEGUE and CLAIRE LUGNIER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33348.x

  4. Part III. Biochemistry Pharmacology

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Calcium Antagonist Receptors : Clinical and Physiological Relevance (pages 116–133)

      JOHN A. WAGNER, SANDY E. GUGGINO, IAN J. REYNOLDS, ADELE M. SNOWMAN, AMITAVA BISWAS, BALDOMERO M. OLIVERA and SOLOMON H. SNYDER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33349.x

    2. Molecular Properties of Structure and Regulation of the Calcium Channel (pages 134–149)

      MICHEL LAZDUNSKI, JACQUES BARHANIN, MARC BORSOTTO, CHRISTIAN COGNARD, CHRISTIE COOPER, THIERRY COPPOLA, MICHEL FOSSET, JEAN-PIERRE GALIZZI, MARLENE M. HOSEY, CHRISTIANE MOURRE, JEAN-FRANCOIS RENAUD, GEORGES ROMEY, ANNIE SCHMID and SYLVIE VANDAELE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33350.x

    3. Purification and Reconstitution of Calcium Channel Drug-Receptor Sites (pages 150–161)

      HARTMUT GLOSSMANN, JÖRG STRIESSNIG, LIN HYMEL and HANSGEORG SCHINDLER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33351.x

    4. Molecular Properties of Dihydropyridine-Sensitive Calcium Channels (pages 162–175)

      MICHAEL J. SEAGAR, MASAMI TAKAHASHI and WILLIAM A. CATTERALL

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33352.x

    5. Mechanism of Action of Calcium Channel Modulator Drugs : Identification of a Unique, Labile, Drug-Binding Polypeptide in a Purified Calcium Channel Preparation (pages 176–186)

      PAL L. VAGHY, KIYOSHI ITAGAKI, KUNIHISA MIWA, EDWARD McKENNA and ARNOLD SCHWARTZ

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33353.x

    6. Plasticity of Neuronal L-Type Calcium Channels (pages 187–198)

      S. GOVONI, F. BATTAINI, S. M. MAGNONI, L. LUCCHI, R. A. RIUS and M. TRABUCCHI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33354.x

  5. Poster Papers

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Calcium Channel Binding Sites in Human Brain (pages 203–206)

      RÉMI QUIRION, SAMARTHJI LAL, ANDRÉ OLIVIER, YVES ROBITAILLE, N. P. VASSAVAN NAIR, ROBERT M. FORD and JOSEPH G. STRATFORD

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33356.x

  6. Part IV. Physiology and Pharmacology

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Actions of Calcium on Smooth Muscle : Historical Overview (pages 210–215)

      DAVID F. BOHR

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33358.x

    2. Calcium and Vascular Myogenic Tone (pages 216–225)

      ISMAIL LAHER, JOYCE HWA and JOHN A. BEVAN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33359.x

    3. Calcium and Activation of the Release of Endothelium-Derived Relaxing Factor (pages 226–233)

      GABOR M. RUBANYI and PAUL M. VANHOUTTE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33360.x

    4. Calcium Antagonism and Vascular Smooth Muscle (pages 234–247)

      J. M. VAN NUETEN, W. J. JANSSENS and P. M. VANHOUTTE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33361.x

    5. Effects of Calcium “Antagonists” on Vertebrate Skeletal Muscle Cells (pages 259–268)

      L. A. HELLAND, J. R. LOPEZ, S. R. TAYLOR, G. TRUBE and L. A. WANEK

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33363.x

    6. The Effect of Calcium Channel Antagonists on Peripheral Neurones (pages 269–277)

      RICHARD J. MILLER, DOUGLAS A. EWALD, AARON P. FOX, LANE D. HIRNING, EDWIN W. McCLESKEY, TERESA M. PERNEY, MICHAEL STUREK, STANLEY A. THAYER, RICHARD W. TSIEN and MARY W. WALKER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33364.x

    7. Calcium Entry and Activation of Endocrine Cells (pages 284–295)

      WILLY J. MALAISSE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33366.x

  7. Poster Papers

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Nisoldipine Enhances Capillary Recruitment in the Heart (pages 298–300)

      PAUL F. McDONAGH

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33368.x

    2. Role of Calcium Channels in the Rat Esophageal Tunica Muscularis Mucosae (pages 301–303)

      S. E. OHIA, Y. D. CHEUNG, D. BIEGER and C. R. TRIGGLE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33369.x

    3. PN 200–110, a Calcium Antagonist with High Potency and Selectivity for Vascular Smooth Muscle (pages 304–305)

      URS T. RÜEGG, GÜNTER SCHOLTYSIK, NIGEL S. COOK, ARNOLD VOGEL and ROBERT P. HOF

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33370.x

  8. Part V. Modulatory Influences

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Calcium Channels in Smooth Muscle (pages 312–327)

      T. GODFRAIND

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33373.x

    2. Calcium Transients in Smooth Muscle (pages 328–337)

      KATHLEEN G. MORGAN, ARLENE BRADLEY and TIA T. DeFEO

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33374.x

    3. The Effects of Ca2+ Antagonists on Isolated Rat and Rabbit Mesenteric Resistance Vessels : What Determines the Sensitivity of Agonist-Activated Vessels to Ca2+ Antagonists? (pages 338–350)

      CYNTHIA CAUVIN, MAITE TEJERINA, OK HWANG, MIEKO KAI-YAMAMOTO and CORNELIS van BREEMEN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33375.x

    4. Receptor Subtypes Involved in the Action of Calcium Entry Blockers (pages 351–360)

      P. A. van ZWIETEN and P. B. M. W. M. TIMMERMANS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33376.x

  9. Poster Papers

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
  10. Part VI. Pathophysiology

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Ca2+ Antagonists and Vascular Disease (pages 380–389)

      PAUL M. VANHOUTTE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33379.x

    2. Calcium Antagonists and Low Density Lipoprotein Receptors (pages 390–398)

      R. PAOLETTI, F. BERNINI, R. FUMAGALLI, M. ALLORIO and A. CORSINI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33380.x

    3. Calcium Antagonists as Antiatherogenic Agents (pages 411–419)

      PHILIP D. HENRY

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33382.x

    4. Protection of Arterial and Arteriolar Wall Structure by Specific Calcium Antagonists (pages 420–432)

      M. FREY, J. ZORN, A. FLECKENSTEIN and G. FLECKENSTEIN-GRÜN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33383.x

    5. Pathophysiology of Cardiomyocytes (pages 433–453)

      M. BORGERS, L. VER DONCK and G. VANDEPLASSCHE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33384.x

    6. Metabolism of Arachidonic Acid (pages 454–463)

      S. MONCADA and E. A. HIGGS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33385.x

    7. A Potential Role of Calcium Ions in Early Ischemic and Reperfusion Arrhythmias (pages 464–477)

      L. H. OPIE, W. A. COETZEE, S. C. DENNIS and F. T. THANDROYEN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33386.x

    8. Brain Ischemia as a Target for Ca2+ Entry Blockers (pages 478–490)

      A. WAUQUIER, D. ASHTON and G. H. C. CLINCKE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33387.x

    9. Pharmacological Basis and Therapeutic Efficacy of Flunarizine in Peripheral Artery Disease (pages 491–501)

      T. DI PERRI, F. LAGHI PASINI, S. PECCHI, L. DOMINI, L. RALLI, M. MATERAZZI, V. DE FRANCO, A MONACI and L. CECCATELLI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33388.x

    10. Ischemic Vasoconstriction and Parenchymal Brain pH (pages 502–515)

      FREDRIC B. MEYER, THORALF M. SUNDT JR., ROBERT E. ANDERSON and PHILLIP TALLY

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33389.x

  11. Poster Papers

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. The Antiatherosclerotic Effect of Anipamil in Cholesterol-Fed Rabbits (pages 519–521)

      A. L. CATAPANO, F. M. MAGGI and U. CICERANO

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33391.x

    2. Long-Lasting Protective Effect of Anipamil, a New Calcium Entry Blocker, against Myocardial Ischemia and Reperfusion Damage (pages 522–524)

      R. FERRARI, C. CECONI, S. CURELLO, A. CARGNONI, R. RADDINO, G. CIAMPALINI and O. VISIOLI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33392.x

    3. Cardioprotective Actions of Nisoldipine in Postreinfusion Myocardial Ischemia (pages 527–530)

      RICHARD K. MENTLEY and ALLAN M. LEFER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33394.x

    4. Effect of Verapamil on Doxorubicin-Induced Cardiomyopathy (pages 533–535)

      F. PICCININI, E. MONTI, L. FAVALLI and F. VILLANI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33396.x

  12. Part VII. Cardiovascular Diseases

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Control of Cardiac Arrhythmias by Calcium Antagonism (pages 536–552)

      KOONLAWEE NADEMANEE and BRAMAH N. SINGH

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33397.x

    2. Calcium Antagonists in Heart Failure (pages 553–564)

      SPENCER H. KUBO, MARIA TERESA OLIVARI and JAY N. COHN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33398.x

    3. Calcium Antagonists for Angina Pectoris (pages 565–583)

      P. G. HUGENHOLTZ

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33399.x

    4. Calcium Antagonists and Their Potential for Antihypertensive Therapy (pages 584–599)

      F. R. BÜHLER and W. KIOWSKI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33400.x

    5. Myocardial Protection (pages 600–610)

      W. FLAMENG

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33401.x

  13. Poster Papers

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Influence of Verapamil on the Body Sodium/Fluid Volume State and Noradrenergic-Dependent Blood Pressure Regulation in Patients with Essential Hypertension (pages 621–622)

      C. BERETTA-PICCOLI, C. MARONE, P. STÄDLER, W. H. ZIEGLER, W. RIESEN and C. PUSTERLA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33403.x

    2. Acute Effects of Feliodipine on Regional Blood Flow in Chronic Heart Failure (pages 623–624)

      G. BINETTI, R. SPADONI, I. RUBINO, E. VARANI, R. M. FERRETTI, S. PANCALDI, V. CERVI and B. MAGNANI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33404.x

    3. Predictive Factors of the Acute and Chronic Blood Pressure Fall Induced by the Calcium Antagonist Nicardipine (pages 625–627)

      GILLES CHATELLIER, PASCAL CLUZEL, MARC BELLET, JOSEPH RIVALAN, PIERRE CORVOL and JOËL MENARD

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33405.x

    4. Cardiovascular Effects of Dihydropyridine Calcium Channel Antagonists and Their Relation to Drug Levels in Plasma (pages 628–629)

      K.-H. GRAEFE, R. ZIEGLER, W. WINGENDER, K.-D. RÄMSCH and G. AHR

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33406.x

    5. Comparative Evaluation of Two Calcium Antagonists, Nicardipine and Nifedipine, in Patients with Mild to Moderate Chronic Heart Failure : A Noninvasive Study (pages 630–631)

      C. MAZZOLA, E. E. GUFFANTI, A. VACCARELLA, D. TURRI, M. NAZZARI and G. FIORELLA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33407.x

    6. Chronic Administration of Slow-Release Nifedipine Improves Arterial Compliance in Elderly Hypertensives with Systolic Hypertension (pages 632–635)

      S. NOVO, G. DAVÍ, E. NARDI, F. ZINGONE, M. FLORIDIA, G. CENTINEO, G. NOTO, G. LICATA and A. STRANO

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33408.x

    7. Effects of Middle-Term Treatment with Nifedipine on Hemodynamic Parameters and on Left Ventricular Function in Hypertensive Patients (pages 636–637)

      R. SCAGLIONE, G. PARRINELLO, G. CAPUANA, M. A. DICHIARA, G. MAZZOLA, N. ASTA, S. NOVO and G. LICATA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33409.x

  14. Part VIII. Neurological Disease

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Therapeutic Window for Pharmacological Treatment in Acute Focal Cerebral Ischemia (pages 662–666)

      C. FIESCHI, C. ARGENTINO, G. L. LENZI, L. FANTOZZI, M. L. SACCHETTI, A. PACE, M. RASURA, S. BASTIANELLO, L. BOZZAO, E. ZANETTE, C. BUTTINELLI, F. GIUBILEI and P. PANTANO

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33411.x

    2. Use of a Calcium Antagonist in Aneurysmal Subarachnoid Hemorrhage (pages 667–675)

      LENNART BRANDT, BENGT LJUNGGREN, HANS SÄVELAND and KARL-ERIK ANDERSSON

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33412.x

    3. Calcium Entry Blockers in the Treatment of Vertigo (pages 690–697)

      J. OLESEN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33414.x

    4. Pharmacology of Nimodipine : A Review (pages 698–706)

      A. SCRIABINE and W. van den KERCKHOFF

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33415.x

  15. Poster Papers

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Improvement of Parkinsonism after Withdrawing Long-Term Flunarizine Treatment (pages 707–709)

      F. BENVENUTI, A. BARONI, S. BANDINELLI, R. CORRADETTI, N. MARCHIONNI, F. M. ANTONINI and T. PANTALEO

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33416.x

    2. Flunarizine in Epilepsy (pages 710–711)

      C. D. BINNIE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33417.x

    3. Safety Profile of Flunarizine : A Retrospective Study in Migraine and Cerebrovascular Disorders (pages 712–715)

      G. BONO, N. MARTUCCI, P. MERLO, R. CERBO, G. NAPPI and A. AGNOLI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33418.x

    4. Specific Effects of Nimodipine on the Auditory System (pages 716–718)

      P. J. JASTREBOFF and J. F. BRENNAN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33419.x

    5. Pharmacokinetics and Metabolism of Radiolabeled Nimodipine (page 719)

      J. LETTIERI, G. KROL, K.-D. RÄMSCH, S. YEH, F. G. McMAHON, J. RYAN, A. JAIN and B. KAMATH

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33420.x

    6. Calcium Entry Blockers in the Prophylaxis of Migraine (pages 720–722)

      JES OLESEN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33421.x

    7. Lumbar and Cisternal Cerebrospinal Fluid Level of Arachidonate Metabolites in Nimodipine-Treated Patients after Subarachnoid Hemorrhage (pages 723–726)

      RICCARDO RODRIGUEZ Y BAENA, PAOLO GAETANI, VITTORIO SILVANI, GUIDO GRIGNANI, GIANCARLO FOLCO and PIETRO PAOLETTI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33422.x

    8. New Opportunities with a Calcium Overload Blocker in Brain Protection? (pages 727–728)

      T. PETERS and K. U. SEILER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33423.x

  16. Part IX. Other Therapeutic Indications

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. The Role of Calcium Channel Blockers in Reactive Airway Disease (pages 732–746)

      ROBERT G. TOWNLEY, J. CHENG, A. K. BEWTRA, N. NAIR, R. HOPP and D. K. AGRAWAL

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33425.x

    2. Calcium Antagonists and Dysmenorrhea (pages 747–756)

      K.-E. ANDERSSON

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33426.x

    3. Protection of Liver by Calcium Entry Blockers (pages 757–770)

      RONALD G. THURMAN, ELIZABETH APEL, MOSTAFA BADR and JOHN L. LEMASTERS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33427.x

    4. Calcium Antagonists and the Renal Hemodynamic Response to Vasoconstrictors (pages 771–784)

      RODGER LOUTZENHISER and MURRAY EPSTEIN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33428.x

    5. Effects of Calcium Antagonists on Renal Function (pages 785–792)

      JOHN H. BAUER and GARRY P. REAMS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33429.x

  17. Poster Papers

    1. Top of page
    2. Part I. Physiology
    3. Poster Papers
    4. Part II. Biochemistry
    5. Part III. Biochemistry Pharmacology
    6. Poster Papers
    7. Part IV. Physiology and Pharmacology
    8. Poster Papers
    9. Part V. Modulatory Influences
    10. Poster Papers
    11. Part VI. Pathophysiology
    12. Poster Papers
    13. Part VII. Cardiovascular Diseases
    14. Poster Papers
    15. Part VIII. Neurological Disease
    16. Poster Papers
    17. Part IX. Other Therapeutic Indications
    18. Poster Papers
    1. Dihydropy ridine Calcium Channel Blocking Agents in Hepatotoxic and Ethanol-Induced Liver Cell Injury (pages 793–795)

      ERWIN J. LANDON, MELANIE SURBER and B. V. RAMA SASTRY

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33430.x

    2. Nitrendipine : An Antidote to the Lethal Toxicity of Cocaine (pages 796–798)

      G. NAHAS, R. TROUVÉ, C. LATOUR, M. SITBON and J.-F. DEMUS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb33431.x

SEARCH

SEARCH BY CITATION